Dr. George M. Nassar, MD

Dr. Nassar practices at DaVita Northstar Dialysis Center in Houston, Texas.

Dr. Nassar's NPI, 1639171416, was assigned on August 11, 2005. Dr. Nassar graduated from American University of Beirut Faculty of Medicine in 1988. Dr. Nassar holds Texas license K4168.

Dr. Nassar's primary practice is DaVita Northstar Dialysis Center, at 380 W Little York, Houston, TX 77076 in Harris County. The practice phone is (281) 448-4506.

Dr. Nassar's primary practice is DaVita Northstar Dialysis Center in Houston, Texas. Dr. Nassar is also affiliated with Houston Methodist Hospital. The medical group on file is Legacy Healthcare Services. Dmand AI also links Dr. Nassar to 4 more hospitals, 4 dialysis centers, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nassar practices, 13 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Nassar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Nassar is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Nassar's licenses on file in 2 states: Texas and Georgia.

Dmand AI lists chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Dr. Nassar treats.

CMS data shows 2,732 Medicare services from Dr. Nassar across 20 procedure codes in 2024, for 398 Medicare patients. Medicare paid $185,013 for them.

CMS counts 398 Medicare patients who saw Dr. Nassar in 2024. The largest group is under 65, with 162 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 21% are also on Medicaid. Their average risk score is 5.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nassar's median patient age at 66, with 46% women.

In 2024, Dr. Nassar wrote 4,050 Medicare Part D claims for 434 patients. 90% of them were for generic drugs. CMS names the drug for 3,672 of them, across 74 drugs with 11 or more claims each, at $537,023 in total drug cost. In 2023, CMS named 3,200 claims across 69 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Nassar for performance year 2024, reported as part of a group. Dr. Nassar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nassar as offering telehealth.

Dmand AI links 43 papers to Dr. Nassar, published from 2006 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Renal Dialysis, Arteriovenous Shunt, Surgical and Graft Occlusion, Vascular. Dr. Nassar has published most often in J Vasc Access. Dr. Nassar's most frequent co-authors are Gerald A. Beathard, MD, Luan Dinh Truong, MD and Katafan A. Achkar, MD.

CMS Open Payments shows 660 general payments to Dr. Nassar from 57 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. Eli Lilly and Company paid the most, $23,531. It also lists 16 research payments totaling $1,208 in 2019.

Dmand AI lists 1 award for Dr. Nassar.

Dr. Nassar graduated from American University of Beirut Faculty of Medicine in 1988. Dr. Nassar is a member of ACP, American Society of Diagnostic and Interventional Nephrology- ASDIN and ASN.

Dr. Nassar is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.